Dr R Helmut Rupp appointed president, Hikal Technologies
17 Sep 2007
Mumbai: Global life sciences and specialty chemicals outsourced manufacturer Hikal Ltd. today announced the appointment of Dr R Helmut Rupp as the president of its new contract R&D company Hikal Technologies, the 100-per cent subsidiary of Hikal Ltd.
Dr Rupp has earlier worked with Hoechst AG, Germany, Lonza, Switzerland and Allessa Chemie, Germany, mainly in the field of pharmaceuticals and fine chemicals. His experience encompasses a mix of scientific, technical as well as managerial roles.
"We are
pleased to announce Dr Helmut Rupp''s appointment as the president of Hikal Technologies
and welcome him," said Jai Hiremath, vice chairman and managing director,
Hikal. "Dr Rupp''s background and leadership will be crucial for the success
of our new contract R&D company. He brings with him rich experience and strong
leadership capabilities, which will prove to be a real asset. We look forward
to his leadership in building a world-class company that caters to creating intellectual
property for our global customers."
The
70,000 sq. ft. R&D facility will employ approximately 100 scientists in the
first phase and serve as a hub for contract research support services. It will
provide chemical contract research services for clients in the pharmaceuticals,
biotech and specialty chemical industries. Special emphasis will be given to safety
and scalability of processes provided, in order to facilitate smooth transfer
to piloting and manufacturing operations.